Sino Biopharmaceutical Financial Overview
Sino Biopharmaceutical's market cap is currently $14.77B. The company's EPS TTM is $0.026611588000000002; its P/E ratio is 28.86; and it has a dividend yield of 1.40%. Sino Biopharmaceutical is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
